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Germline variation in genes that encode the human T cell receptors (TCRs) may have an important 
influence in shaping the immune T  cell repertoire.  In this report we describe a frequent null 
allele of the human VB18 gene, resulting from a nucleotide substitution that creates a stop codon 
(CGA~  Approximately 11% of the population tested was homozygous for this null allele, 
indicating that this is a frequent "hole in the repertoire" We confirmed that there is a greatly 
reduced (undetectable) level of V318 mKNA in peripheral blood lymphocytes from an individual 
homozygous for this null allele. In addition, all heterozygous individuals expressed detectable 
levels of only the functional V/318 allele in their peripheral blood lymphocytes. Two other DNA 
polymorphisms were identified in VB18, one of which would result in an amino acid substitution 
in an expressed V~18 gene. Genotypes for all three of these V/318 DNA polymorphisms were 
determined in a group of unrelated individuals. Statistical analyses of the associations between 
alleles of the V318 polymorphisms and those of other DNA polymorphisms in the TCR 3 
locus suggested a close physical proximity between the VB18 gene and the 3' end of the C~2 
region. This localization of human V318 had been previously predicted by the sequence homology 
between human V~18 and mouse VB14, a V gene segment previously mapped to 3' of the mouse 
C3 genes. We confirmed this localization of the human V318 gene by isolating a cosmid done 
that contains both the V318 and C~2 gene segments. Mapping by restriction enzyme digestion 
and by the polymerase chain reaction indicated that the V318 gene segment is approximately 
9 kb 3' of the C32 gene, making this the only known human V3 gene 3' of the C3 region. 
A  diverse repertoire of TCKs is generated by a variety of 
somatic mechanisms, including the random rearrange- 
ment of gene segments, N region diversification, and junc- 
tional diversity. In addition to these somatic effects, allelic 
variations  arising from DNA polymorphisms in the TCR 
genes also contribute to germline diversity in the population 
(1). In the past, RFLPs detected with probes from TCR V 
genes were used as indirect measures ofDNA polymorphism 
within the V genes (2-6). More recently, however, direct se- 
quence analysis has demonstrated the presence of germline 
DNA polymorphisms in the TCR that result in amino acid 
substitutions.  Specifically, Robinson (7) has reported a poly- 
morphism in the V31 gene segment that results in a change 
from glutamine to histidine, while Li et al. (8) reported two 
polymorphisms in the V36.7 gene that result in a serine to 
arginine and also a glycine to glutamic acid substitution. Al- 
though the ultimate impact of these or other allelic varia- 
tions on the TCR repertoire remains to be deteTmined, the 
analysis of TCR polymorphisms may provide a greater un- 
derstanding of the potential relationship between DNA poly- 
morphisms in the TCR and susceptibilities to certain autoim- 
mune diseases (reviewed in references 1 and 9). 
To further assess the extent of TCR germline polymor- 
phism, we have compared the sequence of TCR V gene seg- 
ments from multiple individuals.  In this study,  we report 
a striking example of a DNA polymorphism in the VB18 
gene that results in the introduction of a termination codon 
(the VB18 gene has also been referred to as the V/320 gene 
in another nomenclature by Kimura et al. [ga]). 11% of the 
individuals analyzed were homozygous for this null allele, 
and therefore could not express a functional V318 protein 
product. Analysis of VB18 expression using RNA from PBL 
confirmed this relationship between V318 RNA message and 
the stop codon. Additionally, we have also obtained the en- 
tire genomic sequence of the V~18 gene, and have determined 
its physical location to be at the 3' end of the C region genes. 
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but is syntenic with the location of a homologous TCR V 
gene segment (VB14) previously mapped in the mouse. 
Materials and Methods 
Human DNA and RNA.  A pand of DNAs isolated from the 
lymphoblastoid cell lines of six unrelated Caucasians was used for 
polymorphism screening, and was kindly provided by R. A. Gatti. 
The DNA of  76 Caucasian  parents and certain families  from Centre 
d'Etude du Folyrnorphisme  Humaine (CEPH) (10), pedigrees were 
used for polymorphism typing. For the V1518 expression analysis, 
RNA was isolated from PHA-stimulated PBL from several small 
families (kindly provided by R. Spielman, University of Pennsyl- 
vania, PhiLadelphia,  PA) using the acid guanidinium thiocyanate- 
phenol-chloroform extraction method (11). 
Oh'gonudeotide~  Amplification  primers and ligafion  probes were 
synthesized using a DNA synthesizer (384 or 391; Applied Bio- 
systems, Inc., Foster City, CA). The sequences of amplification 
primers and ligation probes used in polymorphism typing of the 
Vt518 gene segment are shown in Table 1. The 5' allde-speciiic 
ligation probes were biotinylated as previously  described (12), and 
the adjoining 3' reporter probes were phosphorylated using "5'- 
phosphate-on" according  to the manufacturer's  instructions (Clone- 
tech, Palo Alto, CA). Ligation probes were purified  by reverse-phase 
HPLC, and the phosphorylated 3' reporter probes were enzymati- 
cally labeled with digoxigenin as previously described (13). 
DNA Amplification.  DNA samples were amplified  by the PCR. 
For determining the Vf118 genotypes by restriction enzyme diges- 
tion, PCR was performed using a DNA thermal cycler (Perkin- 
Elmer Cetus, Emeryvilh, CA) in a reaction mix containing reac- 
tion buffer (Amersham  Corp., Arlington Heights, IL), nucleotides 
(final concentration, 20 #M each), DNA polymerase (Hot Tub; 
Araersham Corp.) (final concentration,  10 U/ml), 0.3 IzM each 
of  primer Vfl18-3 and Vfl18-4 (Table 1), and 10-100 ng of  genomic 
DNA. The amplification  profile  was 35-40 cycles  of 1 rain at 94~ 
1 min at 60~  and 2 rnin at 72~ 
For determining the Vf118 genotypes by OLA, DNA samples 
were amplified  in a 96-well microtiter plate thermal cycler  (MJ Re- 
search, Watertown, MA). Genomic DNA (10 rig) was mixed with 
a standard PCR buffer (10 mM Tris-HC1, pH 8.3, 50 ram KC1, 
1.5 mM MgClz, and 0.001% gdatin) containing 40 ~M of each 
of the four deoxynucleotide triphosphates, 0.5 ~M of each primer, 
and 10 U/ml of Taq polymerase (Perkin-Elmer Cetus) (14). The 
amplification profile was 40 cycles of 20 s at 93~  40 s at 55~ 
and 90 s at 72~ 
For PCR-based mapping of the H29 cosmid, 50 ng of cosmid 
DNA was mixed with the same mixture of PCR buffer, nucleo- 
tides, and enzyme as described  directly above for amplifying DNA 
in a 96-wall format. The primer pair used for amplification was 
5'-CTGITI~CCIGAAGATTGAG-3'  (3' end of  C~2) and 5'-ACT- 
GGGTGGAGGATAITIGTAAG-3'  (3' end of  V1518). This mix was 
then subjected to 40 cycles of 1 min at 93~  I min at 55~  and 
2 rain at 72~  in a DNA thermal cycler (Perkin-Elmer Cetus). 
The amount of time at 72~  was extended by 5 s after each cycle 
and is essential to amplifying larger DNA products. 
DNA Sequencing.  For purposes of DNA sequencing, a large- 
scale PCR (200/~1) was performed according to the conditions de- 
scribed above. To eliminate an additional manipulation, mineral oil 
was not used during the amplification  so that ethanol p~'ipitation 
was done in the same tube as used for amplification. The concen- 
trated PCR products were purified by electrophoresis through 1% 
low-mehing  point  agarose (Bethesda Research Laboratories, 
Gaithersburg, MD), and the amplified products excised  from the 
gel 10 ~1 of the PCR product in the gel slice was used directly 
as the template for sequencing in 96-well assay plates using the 
Sequenase sequencing  kit (U.S. Biochemical  Corp., Cleveland,  OH) 
(15). The sequencing primers used were the same as those used 
for the original amplification. Sequence from the VB18 gene re- 
gion was obtained using the H29 cosmid. Sequence-specific  oligo- 
nucleotide primers were used to sequence across both strands of 
the cosmid template ('~,2 ~g of cosmid DNA template per labeling 
reaction). Sequencing was done using the Sequenase sequencing 
kit, and the annealing and radiolabeling steps were performed at 
37~  (15). 
Restriction Digestion Analysis.  R~striction digestion of the PCR 
products was performed without further purification of  the DNA. 
10 ~1 of  the amplified  DNA was digested with 10 U of  either KpnI 
or Sau3A (Bethesda Research Laboratories). Only the addition of 
BSA (final concentration, 100 ~g/ral) was necessary  for complete 
digestion with KpnI, whereas addition of the manufacturer's 10 x 
digestion buffer was required for digestion with San3A. Restric- 
tion enzyme-digested PCR products were subjected  to electropho- 
resis in a 3% agarose gel (including 2% Nusieve agarose; FMC 
Bioproducts, Rockland, ME) containing ethidium bromide, and 
visualized by UV iUumination. 
Oligonucleotide Ligation Assay (OLA). 1  Analyses  of amplified 
DNA saraples using primers V~18-1 and -2 for each of the V1318 
polymorphisms were performed using an OLA detection system 
previously described in detail (13, 14). In this assay, each sample 
was analyzed by a ligation reaction for each allele. Each reaction 
contained one of the 5' biotinyhted probes specific  for that allelic 
form of the polymorphism, the common 3' reporter probe labeled 
with digoxigenin, an aliquot of the amplified DNA target, and 
T4 DNA ligase. If the  probes were hybridized  to a perfectly  matched 
target, the biotinyhted allele  specific  and reporter  probes were  joined 
by the ligase. To determine whether the ligation reaction had been 
successful, the reaction was transferred to a streptavidin plate to 
capture the biotinylated probe. The plate was washed and then as- 
sayed for the presence of the covalently  attached reporter molecule 
using an enzyme-linked immunoassay system (13). 
Cosmid Identification and Restriction Digest Mapping.  A human 
cosmid library constructed in a modified pWE15 vector (16) and 
containing 15 genome equivalents was screened for V~18. The 
cosmid H29 was identified by hybridization (final stringency was 
0.Sx  SSC at 65~  to a PCR-amplified V~18 gene segment that 
had been cloned into the M13 phage. The H29 cosmid was mapped 
with EcoRI, HindlII, BamHI, and XbaI using a standard protocol 
of partial digestion, and then sequential hybridization with vector- 
specific  oligonudeotides (final  stringency  wash of6x SSC at 65~ 
and to TCR Cfl and Vf118 probes. 
V~18 RNA Expression.  For PCR analysis  of RNA, eDNA was 
synthesized  from 1-2 ~g of  total RNA by random hemmer priming 
using a eDNA synthesis kit (Amersham Corp.). Approximately 
25 ng of the eDNA was PCR amplified with 25 cycles using a 
5' Vf118 and 3' Cfl together with a 5' and 3' C~ primer pair, as 
listed in Fig. 6, b and c, legends. The products were subjected to 
dectrophoresis at 150 V through 2% agarose and vacuum blotted 
with 0.4 N NaOH onto Genetran nylon membrane (Plasco, Marl- 
boro, MA). The membrane was hybridized overnight to a Cfl and 
CoL DNA probe that were 32p radiolabded separately  by random 
priming. These probes had been combined as a 50:50 mixture based 
on the amount of incorporated 3zp. The hybridized blot was then 
1 Abbreviation used in this paper: OLA, oligonucleotide  ligation assay. 
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The PCK products were detected by autoradiography. 
Linleage Disequilibrium  Analysis.  Statistical  analysis of linkage 
disequilibrium between loci was tested using the Q statistic (17). 
This statistic measures the total linkage disequilibrium between 
the alleles at two loci by summating the differences  between the 
observed frequencies  of the alhle combinations and those frequen- 
des expected if one assumed random association of alleles at the 
two loci. Linkage disequilibrium was also assessed  using a normal- 
ized measure for disequilibrium, D' (18), which describes the ex- 
tent of  disequilibrium in terms of  the fraction of  maximum (• 1.0) 
linkage disequilibrium possible for that locus pair. Since genetic 
phase was not established, individuals who were heterozygous at 
both loci in a pair-wise  comparison  were not included  in the linkage 
disequilibrium calculation. 
Results 
Genomic Sequence of the  Vff18 Region.  To  obtain  the 
genomic sequence of the human V/318 region, a cosmid (H29) 
was isolated by hybridization to a V/~18 probe. Using a se- 
ries of primer-directed sequencing walks along both strands 
of the cosmid DNA, the entire V/318 coding sequence was 
obtained as listed in Fig. 1. This sequence extends from the 
leader region, through the first intron and the u  gene 
segment, and ends within the 3' noncoding sequence.  The 
3' noncoding sequence also includes the recombination signal 
(heptamer-nonamer sequences) for somatic DNA rearrange- 
ment. One of the interesting features of the human V~18 
gene sequence  is its similarity to mouse V/~14 (19). This 
similarity across species is 77% in the coding regions, and 
63%  overall. 
Identification of Sequence Polymorphisms in the Human VB18 
Gene  Direct sequencing of the amplified germline V/~18 
gene segment from multiple persons revealed three DNA poly- 
morphisms in the u  gene segment. The positions of the 
DNA polymorphisms in the V/~18 gene segment are shown 
in Pig.  1. All three polymorphisms were single nucleotide 
substitutions involving C  to T  base transitions. From the 
amino acid translations, two polymorphisms, one at nudeo- 
tide  524  and  the  other  at  nucleotide  620,  would  have 
significance with regard to the V/~18 protein product. Most 
importantly, the polymorphism at position 524 leads to the 
introduction of a stop codon in the V/318 gene sequence. The 
nucleotide substitution at position 620 would result in a proline 
to serine amino acid substitution in the gene product. 
Genotyping of the Vff18 Polyraorphbms.  Genotypes for the 
#etLeuCysSerLeuLerAlaLeuLeuLeuGlyThrPhePhe 
A.  ATG•T•TG•T•T•T••TTGC••TT•T••TGGG•A•TTT•TTTGgt•ggtgccctcctc•ctgcaagcctctt••ctca•c  80 
B.  -  ............................................................................... 
C.  ................................................................................ 
A.  ctcacctccaccccaatcccgt•aatgcagagtctgagct••tggtttgacactcttgag•ctattcc•gattgtctgga  160 
m.  -  ............................................................................... 
C.  -  ............................................................................... 
A.  aca•ata••g•aatttagcc•tagg•gctgatc••atgattcttagt•ctctc•atctcctgagaa•gagttc•t•ct•t  240 
B.  -  ............................................................................... 
C.  -  ............................................................................... 
A.  tggtcttccctggcccagga•gctt•gcatccttggctcccccagtc•ac•ccccat.gatggattccaggtgcctg•g•c  320 
B.  ................................................................................ 
C,  -  ............................................................................... 
A.  a•gcaagagc•tgagctgcccctc•gtctggggaaggcaagcca•gct•g•g•gctcctctgtaaatggcac•tta•ct•  400 
e.  -  ............................................................................... 
C.  -  ............................................................................... 
GlyVa 1ArgSerG lnThrl leHfsGlnTrpPreA 1  aThrLeuVa lGlnProVa 1GlySerProLeuSerLeuGlu 
A.  tccacagGGGTCAGATCTCAGACTATTCATCAATGGCCAGCGACCCTGGTGCAGCCTGTGGGCAGCCCGCTCTCTCTGGA 480 
CysThrVa~G~uG~yThr$erAsnPr~AsnLeuTyrTrpTyrAr9G~nA~aA~aG~yA~G~yLeuG~nLeuLeuPheTyr 
A.  GTGCACTGTGGAGGGAACATCAAACCCCAACCTATACTGGTACCGACAGGCTGCAGGCAGGGGCCT•CAGCTGCTCTTCT  560 
B.  ~ ............................................................................... 
C.  - ..........................................  T .................................... 
Stop 
SerValGlyZleGlyGlnIleSerSerGluValPro61nAsnLeuSerAlaSerArgProGlnAspA~GlnPhelle 
A.  ACTCCGTTGGTATTGGCCAGATCAGCTCTGAGGTGCCCCAGAATCTCTCAGCCTCCAGACCCCAGGACCGGCAGTTCATC 640 
C.  - ..........................................................  T .................... 
Set 
LeuSerSerLysLysLeuLeuLeuSerAspSer61yPheTyrLeuCysA 1  aTrpSer 
A.  ~,.~r  720 
B.  - ...................  T ........................................................... 
C.  ....................  T ........................................................... 
A.  gacatctgtgceueaccccaccctctcctgagccctaaccat actccccagggccttcacttagggactgggtggagga  800 
B.  -  .................................. 
C.  -  .................................. 
tatttgtaagtaggttetqactactaaccaatataaagc  839 
Figure  1.  Complete genomic 
DNA and amino acid sequence of 
the human V/318 gene segment. 
The DNA and amino  acid  sequence 
polymorphisms  are shown  at posi- 
tions 524, 620, and 661. The actual 
DNA sequence of the three V~18 
haplotypes  observed  is indicated  by 
the A, B, and C lines (-, identical 
sequence). The heptamer-nonamer 
somatic  recombination signals 
found in the 3' noncoding  region 
are  italicized and  bolded. PCK 
primers used to amplify  this gene 
segment  are underlined.  The double- 
underlined DNA sequences were 
found  to be different  compared  with 
the original reported eDNA se- 
quence of HUT102 (20), and were 
not found to represent additional 
polymorphism.  These sequence  data 
are available  from  EMBL/GenBank/ 
DDBJ under accession number 
Z13967 HSTCRVB18. 
137  Charmley  et al. Figure 2.  Mendelian  segregation  of the KpnI and Sau3A V~18 DNA 
polymorphisms.  The VB18 gene  was amplified  using  primers  VB18-3 and 
-4 from  the individuals  in a three-generation  pedigree  (F, father;  M, mother; 
c, child;  g, grandparent). The PCR products were digested  with either 
the KpnI or Sau3A restriction  enzyme  and genotypes  were determined 
based on the polymorphic  DNA fragments  observed.  The pointers  on the 
left indicate  the allelic  restriction  fragments,  with the  joined  pointers  (after 
KpnI digestion)  indicating a single  allele  (though the lower  fragment  is 
noticeably  faint in the heterozygotes).  Sau3A digestion also resulted  in 
a monomorphic  DNA fragment  present  in all individuals.  On the far right, 
sm indicates the 123-bp ladder used as a size marker. 
V~18 polymorphisms were determined for a larger group 
of individuals. First, according to the DNA sequences sur- 
rounding the polymorphisms at nucleotide positions 524 and 
620 (Fig.  1), these polymorphisms would result in altering 
restriction enzyme recognition sites. The base change at po- 
sition 524 alters a KpnI restriction site, and the DNA poly- 
morphism at position 620 changes a San3A restriction site, 
as demonstrated in Fig. 2. Genotypes for all three V~18 poly- 
morphisms were obtained using the semi-automated OLA 
typing system. Analysis of the inheritance patterns for these 
three DNA polymorphisms revealed proper Mendelian segre- 
gation, as shown in Fig. 3. The segregation of the V818 geno- 
types was completely compatible with cosegregation (i.e., 
no recombinants) with haplotypes of the TCR ~ chain pre- 
viously determined in these individuals (6). 
Within  our  tested population  (152  chromosomes),  the 
nudentide changes at positions  524  and 620 had identical 
allde frequencies of 68%  for the C  substitution  and 32% 
for the T  substitution.  11%  of the individuals tested were 
homozygous for the T  substitution at nudeotide 524,  and 
therefore, based on the presence of the stop codon, these 11% 
of  the individuals would not produce a functional V:/18 pro- 
rein product. The allde frequency for the silent base substi- 
tution at nucleotide 661  was slightly different from those 
found for the other two polymorphisms (524 and 620),  i.e., 
at position 661  the allele frequency for the C  substitution 
was 53% and the T substitution was 47%. Even though one 
of the substitutions,  524, leads to a stop codon, the geno- 
type distributions for all three polymorphisms were consis- 
tent with Hardy-Weinberg equilibrium. 
Linkage Disequilibrium  Analysis.  We statistically examined 
the extent of association between alldes of the V/~18 poly- 
morphism(s) and alleles of other previously reported TCR 
DNA polymorphisms (Table 2). Because of  complete linkage 
disequilibrium among the three point mutations within the 
V~18 gene (D'  --  1.00),  only three DNA haplotypes were 
observed (as shown in Fig.  1).  The extent of linkage dis- 
equilibrium was also measured between the V~18 polymor- 
phisms and other bialhlic polymorphisms previously studied 
in this same population of CEPH parents (6, 14). Although 
the alleles of the V~18 polymorphisms did not show statistical 
assodation with other V~ gene polymorphisms (Table 2), 
polymorphisms at the 3' end of the TCR ~  gene complex 
(C~2 region) were significantly nonrandomly associated with 
the 524  and 620 V~18 polymorphism(s) (p <0.0001). 
Figure 3.  A composite  figure  assembled  from  pho- 
tographs of microtiter  plates containing  OLA geno- 
types that show Mendelian  segregation  of the three 
Vf118 sequence  polymorphisms.  Microtiter  wells  con- 
taining  the reporte~  group  dig~genin form  a colored 
product (dark  wel/s)  and indicate  a perfect nucleotide 
match  between  the ligating probes and the amplified 
DNA target. 
138  A Polymorphic  Stop Codon in a Human TCR VB Gene Table  1.  DNA Sequences  for the Amplification Primers and Ligation Probes Used in Typing the Vd18 DNA PolTmorphisms 
Amplification 
primers  Sequences 
V/318-1 
v318-2 
v318-3 
V/318-4 
Ligation probes* 
V~18-524 
V318-620 
VB18-661 
GAGTGCACTGTGGAGC~AA 
TCACATTGGCCAGCAGTCAG 
ATTCATCAATGGCCAGCGAC 
GGAGCTTCTTAGAACTCAG 
B-CCCCAACCTATACTGGTACC 
B-CCCCAACCTATACTGGTACT 
B-GAATCTCTCAGCCTCCAGAC 
B-GAATCTCTCAGCCTCCAGAT 
B-TGAGTTCTAAGAAGCTCCTC 
B-TGAGTTCTAAGAAGCTCCTT 
pGACAGGCTGCAGGCAGGG-D 
pCCCAGGACCGC,  CAGTTCAT-D 
pCTCAGTGACTCTGGCTTCTAT-D 
* B, biotin; p, phosphorylated; D, digoxigenin. 
Table  2.  Analysis of Linkage Disequilibrium between V~18 Polymorphisms and Other Polymorphisms in the TCR ff Cene Complex 
V318-524/620" 
and:  Haplotypes  D'*  Q  (X2)  s  V318-661  and:  Haplotypes  D'  Q  (X  2) 
Vfll  140  0.04  oA  Vfll  130  0.07  0.1 
v/38  116  o. 18  1.3  v/38  92  -  0.20  2.9 
V/311  114  -  0.23  1.9  V~11  94  -  0.20  2.5 
C32-1  118  -  0.28  2.2  C/~2-1  102  -  0.30  4.5 
C/~2-5  102  -  1.0  31.4  C/~2-5  94  -  0.35  8.7 
C/~2-6  108  0.69  24.8  C~/2-6  98  0.27  6.4 
C/32-7  98  -  1.0  27.2  C/32-7  92  -  0.37  9.0 
V/~18-661  84  1.0  31.2  VB18-524/620"  84  1.0  31.2 
The order of the polymorphisms compared in this table (top to bottom) is the same as the physical order of the polymorphisms  along the chromosome 
(centromere to telomere) (6,  14). 
* The VJ518 position 524 and 620 polymorphisms are synonymous for this analysis since there was a singular correspondence  between alleles at these 
lod (haplotypes, 86; D', 1.0; Q, 86.0). 
* For D', a value of 1.00 (or -  1.00) indicates maximum linkage disequilibrium; a value of 0.0 would indicate complete random association between 
the loci. 
$ For the Q statistic (x  2 distribution, 1-degree freedom), Q >15 corresponds to p <0.0001, which rejects the null hypothesis of random association 
between the alleles at that pair of loci. 
5'  3' 
C62  V61 8 
vector  VVVV  1  m  vector 
EcoRI  I  II  II  III  I  I  I 
BamHI  I  I 
Hi.d,I  II  I  I  III  I  II 
Xbal  I  I  I  III  1  Kb 
Figure 4.  Restriction map of  the cosmid  insert con- 
raining V1318 and (232 genes. Cosmid H29 was shown 
by hybridization to contain both the V~18 and C~ 
gene segments. A restriction map of the cosmid was 
constructed  by partial digestion and hybridization  with 
either the gene segments or vector sequences. Restric- 
tion sites for EcoKI, BamHI, HindllI,  and XbaI are 
shown as vertical lines below the cosmid. 
139  Charmley et al. Figure 5.  Ethidium bromide- 
stained gel containing the  am- 
plified product from the  H29 
cosmid using a primer located at 
the Y end of the C/32 gene and 
one located  3' of the VB18 gene. 
Lane M contains a size marker 
consisting of a 1-kb ladder. The 
sizes of  the two size  marker  bands 
flanking the amplified  C/52-V/318 
product are indicated to the left. 
Pt~ical Mapping of  the V1~18  Cosmid.  Based on the linkage 
disequilibrium results  (Table  2), we sought to confirm  the 
suggested 3' location of the V/~18 gene relative to CB2. The 
H29 cosmid that contained VB18 was tested for hybridiza- 
tion  to 22 other V/~ families and CB.  Only hybridization 
to a C/3 probe was detected. PCtL was used to confirm that 
this cosmid contained both the V/318 and C/3 genes. Physical 
mapping of the H29 cosmid with four restriction enzymes 
and hybridization with V/318 and C~ probes indicated that 
the VB18 gene was located within  15 kb of the C/~2 gene 
(Fig. 4). Previous studies have shown that the mouse V/314 
gene (gene counterpart of human VB18) has an opposite tran- 
scriptional orientation to that of other VB genes as well as 
the D, J,  and C  gene segments  (20).  By using PCtL with 
the H29 cosmid, we have determined the transcriptional orien- 
tation  of human  VB18 relative to the C/32 gene segment. 
DNA amplification with a primer located just 3' of the end 
of the CB2 gene, in combination with a primer located just 
downstream of the VB18 gene, indicated that the V/318 gene 
segment is located ~9 kb 3' of the C/32 gene (Fig.  5). Since 
these PCtL primers must face each other to amplify the in- 
tervening DNA  sequence,  these data also indicate that  the 
transcriptional  orientation  for human  V/318 is opposite to 
that  of the C/~2 gene,  and therefore similar to the orienta- 
tion  of the mouse VB14 and CB2. 
It is worth noting that several different pairs of amplification 
primers from the 3' end of the CB2 gene and the 3' end of 
the V/318 gene could be used to obtain a similarly sized PCR 
product from cosmid DNA (data not shown).  In addition, 
we were also able to sequence the ends of the 9.5-kb PCR 
product  (Fig.  5)  in  low-melt  agarose  (see  Materials  and 
Methods), which verified the origins of this PCIL product, 
i.e. C/~2 at the 5' end and V/~18 at the 3' end (data not shown). 
V~18 RNA Expression  in Peripheral  Blood.  As a result of 
the  null  allele  for VB18  in  the  population,  we sought  to 
confirm the importance of this polymorphism in the expres- 
sion level of V/318 in individuals homozygous for the V/~18 
stop codon. Several members from three families were tested 
by KpnI restriction  enzyme analysis  of genomic DNA for 
the V/~18 null allele (KpnI-).  Representatives of each of the 
three genotypes were identified (Fig. 6 A) and PCtL was used 
to amplify the V/318 RNA (cDNA) from all these individ- 
uals.  Based on the intensity of the V/318 PCtL product, and 
the control Cot product in each lane,  V~IS-CB message was 
Figure 6.  VB18  DNA genotypes  and RNA expression in PBL of 14 
individuals. (A) PCP,-amplified  VB18  gene segment from genomic  DNA 
was digested  with KpnI. The DNA polymorphism  that results  in the stop 
codon also  destroys  this KpnI site. The family  structures are shown  above. 
(B) The somatically  rearranged V/518 gene was amplified from the PBL 
RNA (cDNA)  of  these  same  individuals. The forward  primer V/318-3 and 
a reverse  C/3 primer (5'-AGTCATTGAGGGCGGGCTG-Y)  produced  the 
larger VB18-containing  product, and each tube also  contained  a TCR Ca 
primer pair (5'-CAGCATTATTCCAGAAGACAC-3',  and 5'-CCTCAG- 
C'I'C~ACCACAGC-3') as a positive  control for amplification. (C) The 
rearranged V1318 gene was amplified from cDNA by PCR using the for- 
ward primer V/318-3 and a reverse C/5 primer (5'-GGCAGACAGGAC- 
CCCTTG-Y); the Cot primer pair listed above  was also included, The 
PCR products were digested with KpnI restriction enzyme to confirm 
that the V/318 null allele (no KpnI site) was not expressed. As a control 
for the VB18-CB KpnI-  allele, the outer lanes (-) contain the PCR 
product to which KpnI enzyme was not added. The Cot PCK-positive 
controls in each lane are not shown. 
detected in the peripheral blood of all individuals, except the 
person homozygous for the stop codon (Fig.  6 B). As even 
stronger evidence of the relationship between the stop codon 
and V/318 expression, the amplified V/318-C~ message was 
digested with KpnI (Fig. 6 C). The results show that in the 
eight individuals  studied who possessed the null allele  (ei- 
ther heterozygous or homozygous individuals),  only the V/~18 
KpnI + allele was expressed at detectable levels in the periph- 
eral blood. 
Discussion 
Alldic variation in the germline DN ', of the TCR genes 
has been suspected to influence the expreb ed TCR repertoire 
by altering amino acids that change the TC.Vs ability to recog- 
nize antigen  and/or MHC.  DNA polymorphisms in TCR 
genes could change the expressed T cell repertoire either qual- 
itatively or quantitatively through  the process of donal se- 
lection and expansion in the thymus or periphery.  It is also 
possible that DNA polymorphisms could influence the quan- 
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ments, or through translational changes such as creating a 
stop codon. The potential for functional relevance of TCR 
polymorphisms has been the basis for many disease associa- 
tion studies that have compared the frequency of various TCR 
DNA polymorphisms in autoimmune and control popula- 
tions (reviewed in references 1 and 9). 
In this study, we describe an extreme example of a func- 
tionally relevant DNA polymorphism that results in the pres- 
ence of a stop codon in the V/318 gene segment. This poly- 
morphism was present in 54%  of the population that we 
studied. Importantly,  11%  of the individuals tested were 
homozygous for this null allele, indicating a lack of cell sur- 
face expression of the V/318 TCR protein. Coincidentally, 
there were two other DNA polymorphisms in the VB18 gene, 
one of which would have resulted in an amino acid change 
from proline to serine,  in the absence of the stop codon. 
The observation of complete allelic association  between 
the V/318 polymorphisms could have implications in terms 
of the origins of these polymorphisms. Since the V/318 al- 
leles at positions 524 and 620 were correlated completely, 
this could be due to the simultaneous "creation" of the poly- 
morphisms in a single ancestral genetic event. A more specula- 
tive but immunological explanation for the complete allelic 
correlation is evolutionary selection at the protein level since 
the alleles of both polymorphisms would affect expression 
and possibly structure. At present time, whenever the serine 
residue is coded for at the second polymorphic site, the ter- 
mination codon is encoded at the first polymorphic site. The 
serine/proline substitution site would occur within the fourth 
hypervariable region in the TCK/3 chain (21) and might be 
involved in antigen/MHC contact. Based on the location of 
this amino acid substitution, and the radical nature of the 
substitution (22), generous speculation might suggest that 
the V/318 haplotype with the stop codon and serine residue 
has been selected to prevent protein expression of the V/318 
with a serine residue at this position. 
The  strong  disequilibrium between  the  C/3-KpnI  site 
(C/32-5; Table 2) and the V/318 polymorphisms has relevance 
to disease association studies since previous studies that have 
used the C/3-KpnI KFLP have therefore indirectly measured 
the V/318 polymorphism association with systemic lupus ery- 
thematosus, multiple sclerosis, and myasthenia gravis (23, 24). 
Also, the lack of any detectable disequilibrium between the 
V/318 polymorphisms and the C/3-BgllI RFLP (CB2-1),  as 
well as the other more distant 5' V/3 KFLPs (Table 2), im- 
plies that the many positive disease associations found with 
those RFLPs (1, 9) cannot be directly explained by the V/318 
stop codon. Vice versa, studies reporting no disease associa- 
tion with the previously reported V/3 and C/3-BgllI RFLPs 
in Table 2 (except C/3-KpnI) cannot conclude that the V/318 
polymorphisms are not involved in the disease susceptibility. 
Physical mapping of the human and mouse TCR/3 gene 
complexes has shown a remarkable conservation in the orga- 
nization of homologous V/3 genes between these two spe- 
cies (19, 25). The human V/318 gene is most similar to the 
mouse V/314 gene based on the high nucleic acid homology 
between these gene segments (77%). Therefore, since the 
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mouse V/314 has been shown to be the only V gene located 
3' of the TCR/3 C  region (26),  it was predicted that the 
human V/318 gene would be located 3' of the C region (19). 
This was suggested by linkage disequilibrium (Table 2) and 
confirmed  by isolating a cosmid that contained both the human 
V/318 and C region C/32 gene. Restriction enzyme and PCR 
mapping of this cosmid showed V/318 to be '~9 kb 3' of the 
C/32 gene segment. This 9-kb distance in humans is similar 
to the 10-kb distance between C/32 and V/314 in mice (26). 
Multiple PCR analyses also showed that the human V/318 
has an opposite transcriptional polarity relative to the TCR/3 
D, J, and C region genes and other V/3 genes, as shown for 
mouse V/314 (26).  Thus, it may similarly be expected that 
human V/318 undergoes a chromosomal inversion to juxta- 
pose V/318 with the D, J, and C  region genes before suc- 
cessful transcription. 
Since the human V/318 gene was originally cloned from 
an acute lymphocytic leukemia cell line (20), and since it is 
3' of C/3 as well as being polymorphic for a stop codon, it 
may be questioned as to the quantitative contribution of a 
functional V/318 protein product to the total TCR/3 reper- 
toire.  Choi et al. (27) estimated that V/318 (V/320 in their 
nomenclature) accounted for ~3.4% of the total V/3 expres- 
sion after anti-CD3 stimulation of peripheral T  cells from 
one individual, while another group failed to detect V/318 
expression in peripheral blood from one donor (28).  V/318 
is a single member subfamily (29),  so there are no other 
V/318 subfamily members that might subsume the role of 
V/318 and prevent this hole in the TCR repertoire caused 
by the null allele. 
Our result showing greatly reduced (undetectable) V/318 
RNA expression  in the peripheral blood of the null allele 
in all eight individuals who possessed the null allele (Fig. 
6, c and b) is consistent with the mechanisms of T cell selec- 
tion that occur in the thymus. The positive or negative selec- 
tion of T  cells in the thymus is dependent on the specific 
ot and/3 proteins on the cell's surface. T cells that rearrange 
and transcribe the nonfunctional V/318 gene segment could 
not be positively selected because they would be unable to 
assemble a TCR a//3 protein heterodimer. Thus, these V/318- 
rearranged cells could not be expected to populate the pe- 
ripheral blood and immune system to an appreciable level. 
In an individual homozygous for the VB18 null allele, a very 
low level of rearranged V/318 message in PBL could be ac- 
counted for by the infrequent additional rearrangement that 
can occur on the other chromosome 7 homologue in T cells 
that express some other V/3 gene on their cell surface. The 
failure to detect V/318-C/3 RNA message from the null allele 
is also consistent with what has been previously seen in mice 
with a similar V/3 stop codon (30, and see below [BALB/c 
v/3191). 
While other polymorphic stop codons have not yet been 
reported in human TCR genes,  there are two examples of 
polymorphic stop codons in mouse TCR V/3 genes. Mouse 
VB19 is expressed in the SJL strain,  but the BALB/c strain 
has deleted a single base in the leader exon that results in 
a frameshift mutation (30). A second example ofa polymorphic 
stop codon in a mouse TCR/3 gene is mouse V/317. Certain strains of mice possess a TCR fl haplotype that  encodes a 
Vf117 gene with a single mutation in the coding region that 
results in a stop codon (31).  Other  strains of mice with a 
functional Vf117 gene have their Vfl17-bearing T ceUs donally 
diminated in those mice that express a certain sdf-superantigen 
and the MHC class II molecule IE (32). Wade et al. 01) specu- 
lated that  although  self-tolerance mechanisms would seem 
to be able to control such autoimmune cells reactive to the 
sdf-superantigen,  perhaps evolutionary pressures have acted 
to provide an additional means of eliminating such autoreac= 
tire T ceils from a portion of the population, via a stop codon. 
It is therefore interesting to note that the T ceils bearing human 
Vf118 appear to be stimulated by the Staphylococcus aureus en- 
terotoxin  superantigens  (27).  This  paraild  between  these 
mouse and human Vfl genes allows similar speculation on 
whether past sdective pressures on humans could have had 
an importance in the pm,  alence of the polymorphic stop codon 
in the human  Vf118 gene. 
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